| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Thin Prep Pap Image Guided, Chlamydia / Gonorrhea / Trichomonas
MessageFor Specimen Integrity during Extreme Weather see the “Lockbox Usage in Extreme Weather” document at the top of this page.
Test Code
P75775
Alias/See Also
75775
CPT Codes
88175 (interp 88141), 87491, 87591, 87661
Includes
Thin Prep (73717RX)
Chlamydia (74506R)
GC (74507R)
Trichomonas (74506R)
Chlamydia (74506R)
GC (74507R)
Trichomonas (74506R)
Instructions
Pap results requiring physician interpretation will be performed at an additonal charge (CPT code(s): 88141). Gynecologic cytology is a screening test which is subject to both false positive and false negative results. For that reason, the test is most reliable when a satisfactory sample is obtained on a regular repetitive basis. Hence, these results must be interpreted in the context of historic and current clinical information.
INSTRUCTIONS: Endocervical Brush/Spatula Protocol:
1. Obtain an adequate sampling from the ectocervix using a plastic spatula
. 2. Rinse the spatula as quickly as possible into the PreservCyt Solution vial by swirling the spatula vigorously 10 times. Discard spatula
. 3. Obtain an adequate sample from the endocervix using the brush device. Insert the brush into the cervix until only the bottom-most fibers are exposed. Slowly rotate 1/4 to 1/2 turn in one direction. DO NOT OVER-ROTATE.
4. Rinse the brush in the same vial as quickly as possible by rotating the device 10 times while pressing the brush against the sides of the vial. Swirl the brush vigorously to further release material.
Broom-Like Device Protocol.
1.Obtain an adequate sampling from the cervix using a broom- like device. Insert the central bristles of the broom into the endocervical canal deep enough to allow the shorter bristles to fully contact the ectocervix. Push gently, and rotate the broom in a clockwise direction five times. 2. Rinse the broom as quickly as possible into the PreservCyt Solution vial by pushing the broom into the bottom of the vial 10 times, forcing the bristles apart, As a final step, swirl the broom vigorously to further release material. Discard the collection device.
After Collection: Tighten the cap so that the torque line on the cap passes the torque line on the vial.
Record the patient's name and ID number on the vial.
Record the patient name and medical history on the pathology requisition, including source of specimen, LMP, hysterectomy status, previous malignancy, radiation therapy, drug therapy, use of exogenous hormones, abnormal vaginal bleeding, abnormal Pap results, IUD, and all other pertinent clinical information.
INSTRUCTIONS: Endocervical Brush/Spatula Protocol:
1. Obtain an adequate sampling from the ectocervix using a plastic spatula
. 2. Rinse the spatula as quickly as possible into the PreservCyt Solution vial by swirling the spatula vigorously 10 times. Discard spatula
. 3. Obtain an adequate sample from the endocervix using the brush device. Insert the brush into the cervix until only the bottom-most fibers are exposed. Slowly rotate 1/4 to 1/2 turn in one direction. DO NOT OVER-ROTATE.
4. Rinse the brush in the same vial as quickly as possible by rotating the device 10 times while pressing the brush against the sides of the vial. Swirl the brush vigorously to further release material.
Broom-Like Device Protocol.
1.Obtain an adequate sampling from the cervix using a broom- like device. Insert the central bristles of the broom into the endocervical canal deep enough to allow the shorter bristles to fully contact the ectocervix. Push gently, and rotate the broom in a clockwise direction five times. 2. Rinse the broom as quickly as possible into the PreservCyt Solution vial by pushing the broom into the bottom of the vial 10 times, forcing the bristles apart, As a final step, swirl the broom vigorously to further release material. Discard the collection device.
After Collection: Tighten the cap so that the torque line on the cap passes the torque line on the vial.
Record the patient's name and ID number on the vial.
Record the patient name and medical history on the pathology requisition, including source of specimen, LMP, hysterectomy status, previous malignancy, radiation therapy, drug therapy, use of exogenous hormones, abnormal vaginal bleeding, abnormal Pap results, IUD, and all other pertinent clinical information.
Transport Container
Thin-Prep(R) Vial
Transport Temperature
Room Temperature
Specimen Stability
Specimen must be processed within 21 days of collection.
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Improperly labeled vial; specimen more than 21 days old (from collection date) in liquid-based preservative; specimen submitted in vial that expired according to manufacturer's label.
Methodology
Microscopic examination of Papanicolau stained slide(s), prepared by the ThinPrep® method. ThinPrep® Imaging System. The pap test is a screening test subject to both false positive and false negative interpretations. Failure to obtain adequate ectocervical, endocervical or vaginal cell population is suboptimal for evaluation. Excessive use of lubricating jelly on the vaginal speculum will interfere with cytologic examination and may lead to unsatisfactory Pap results. Patient should avoid use of douches and personal lubricants 48 to 72 hours prior to examination. Specimen should not be collected during or shortly after menstrual period.
Setup Schedule
Week Days
Cyto
Cyto
Report Available
5 days
Clinical Significance
The pap smear is a screening test used to diagnose premalignant and malignant changes in the uterine cervix and vagina and to diagnose genital infections such as herpesvirus, Candida, Trichomonas vaginalis, etc. Screening pap test - intended for routine pap screening. Diagnostic pap test - intended for follow up pap after a previous abnormal result.
C. trachomatis, the number one cause of sexually transmitted disease in the United States, is responsible for an estimated 3-4 million new cases annually. Infants born to women with chlamydial infection of the cervix are at risk acquiring an infection during vaginal birth. Gonococcal and chlamydial urethritis may coexist. Demonstrating the presence of N. gonorrhoeae is important in initiating appropriate therapy to prevent the spread of infection.
C. trachomatis, the number one cause of sexually transmitted disease in the United States, is responsible for an estimated 3-4 million new cases annually. Infants born to women with chlamydial infection of the cervix are at risk acquiring an infection during vaginal birth. Gonococcal and chlamydial urethritis may coexist. Demonstrating the presence of N. gonorrhoeae is important in initiating appropriate therapy to prevent the spread of infection.
Performing Laboratory
CompuNet Clinical Laboratories, LLC
2308 Sandridge Drive
Moraine, OH 45439
Last Updated: February 15, 2022
